Nurix

parachute chutes
Biotech

Roche, Vir, Neurocrine & more—Chutes & Ladders

Roche bids adieu to pharma vet Sabry. Vir fills vacant CMO spot. Neurocrine maps out CEO succession plan.
fruit

Gilead dives deeper into Nurix protein degrader collab

Apr 2, 2024 9:10am
ocean wave curl

Nurix gets BTK degrader back on track after FDA lifts hold

Mar 11, 2024 9:25am
FDA stop sign

Nurix's cancer drug on partial hold while manufacturing upgraded

Nov 2, 2023 8:40am
Alphabet letters spelling

Are DACs the new ADCs? Seagen pays Nurix $60M to find out

Sep 7, 2023 10:35am
Photo of apples growing on branches with the sun shining in the background

Gilead plucks first fruit from Nurix collab for up to $445M

Mar 20, 2023 12:30pm